Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
164M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+36.3M
-
Total reported value, excl. options
-
$511M
-
Value change
-
+$511M
-
Number of buys
-
37
-
Price
-
$14.11
Significant Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q3 2023
38 filings reported holding NMRA - Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q3 2023.
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 164M outstanding shares and own 22.13% of the company stock.
Largest 10 shareholders include SOFTBANK GROUP CORP. (7.65M shares), FMR LLC (5.62M shares), MIC Capital Management UK LLP (4.46M shares), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31M shares), Artal Group S.A. (2.8M shares), CITADEL ADVISORS LLC (2.17M shares), EcoR1 Capital, LLC (2.07M shares), Avidity Partners Management LP (1.8M shares), HHLR ADVISORS, LTD. (1.7M shares), and ORBIMED ADVISORS LLC (1.5M shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.